Verona Pharma Plc
(NASDAQ) VRNA
Verona Pharma Plc Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$167.65M
Net Income (TTM)
$63.10M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
VRNA News
VRNA: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Verona Pharma Plc
Industry
Pharmaceuticals
Sector
Health CareEmployees
209
CEO
David S. Zaccardelli, PharmD
Website
www.veronapharma.comHeadquarters
London, SE1 2RE, GB
VRNA Financials
Key Financial Metrics (TTM)
Gross Margin
95%
Operating Margin
-26%
Net Income Margin
-38%
Return on Equity
-30%
Return on Capital
-8%
Return on Assets
-11%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$31.71M
Operating Income
$123.51M
EBITDA
$119.79M
Operating Cash Flow
$122.20M
Capital Expenditure
$580.00K
Free Cash Flow
$122.78M
Cash & ST Invst.
$399.76M
Total Debt
$122.70M
Verona Pharma Plc Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$75.14M
N/A
Gross Profit
$71.68M
N/A
Gross Margin
95.39%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
209
N/A
Net Income
$8.69M
+115.5%
EBITDA
$9.91M
+118.6%
Quarterly Fundamentals
Net Cash
$193.64M
+4.1%
Accounts Receivable
$86.92M
+2259.4%
Inventory
$8.61M
N/A
Long Term Debt
$243.36M
+100.9%
Short Term Debt
$1.01M
-1.6%
Return on Assets
-11.01%
N/A
Return on Invested Capital
-8.31%
N/A
Free Cash Flow
$30.56M
+282.1%
Operating Cash Flow
$30.56M
+282.4%